SCHEMBL6134701

SCHEMBL6134701

Cn1nc(-c2c(NCc3ccccn3)nc(N)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.46
ADORA1 P30542 5/20 0.46
HIF1A Q16665 1/20 0.44
ADORA2B P29275 1/20 0.43
ATAD2 Q6PL18 1/20 0.41
KDM4E B2RXH2 4/20 0.40
TLR7 Q9NYK1 4/20 0.40
PDE5A O76074 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HCRTR1 O43613 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
KCNH2 Q12809 3/20 0.39
MAPT P10636 2/20 0.39
USP2 O75604 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133960 0.88 ADORA2A (0.47) ADORA2AADORA1HIF1AATAD2KDM4E
SCHEMBL6133974 0.87 CDK1 (0.44) ADORA2AADORA1HIF1AADORA2BNPSR1
SCHEMBL5149160 0.83 HIF1A (0.45) ADORA2AADORA1HIF1AADORA2BATAD2
SCHEMBL6133480 0.81 ADORA2A (0.43) ADORA2AADORA1HIF1AADORA2BTLR7
SCHEMBL6135243 0.79 ADORA2A (0.40) ADORA2AADORA1HIF1AADORA2BALDH1A1
SCHEMBL6483231 0.78 HIF1A (0.40) ADORA2AADORA1HIF1AADORA2BATAD2
SCHEMBL6133703 0.74 GHSR (0.41) ADORA2AADORA1NPSR1
SCHEMBL5149223 0.74 HIF1A (0.47) ADORA2AADORA1HIF1AADORA2B
SCHEMBL6133364 0.74 ADORA2A (0.43) ADORA2AADORA1
SCHEMBL6133959 0.73 ADORA2A (0.42) ADORA2AADORA1ADORA2BALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043315-A1 Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them ASTELLAS PHARMA INC. (JP) 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043315-A1 Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them ADORA2B, ADORA2A, ADORA1 ADORA2A 2/4885ADORA1 3/4885HIF1A 911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.